TY - JOUR
AU - 
TI - MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase Inhibition
JF - The Journal of Pharmacology and Experimental Therapeutics
DO - 10.1124/jpet.115.227587
DA - 2015-09-25
UR - https://www.deepdyve.com/lp/unpaywall/mli-2-a-potent-selective-and-centrally-active-compound-for-exploring-0hhchfffnK
DP - DeepDyve
ER -